FDA approves new vial size for CSL Behring immune treatment
KING OF PRUSSIA, Pa. — The Food and Drug Administration has approved a new vial size for a treatment for a rare immune system disorder.
CSL Behring announced the approval of a 10-g, or 50-mL, vial size for Hizentra (immune globulin subcutaneous [human]). The product is used to prevent infections in patients with primary immunodeficiency, and the new vial size will be available in October.
Diseases in the PI group affect about 250,000 people in the United States. The company said the new vial size would help reduce the number of vials patients must use when higher doses are required. Hizentra is already available in 1-g, 2-g and 4-g vials.
"CSL Behring remains dedicated to providing every patient with options that will enhance his or her treatment experience," CSL Behring SVP North America commercial operations Lynne Powell said. "The availability of Hizentra in a 10-g vial will reduce vial preparation for infusion, therefore saving time for both patients and their caregivers."
Gillette focuses on precision with top NFL players, Sport Science’s John Brenkus
BOSTON — Procter & Gamble’s Gillette is partnering with four NFL players — Green Bay Packers linebacker Clay Matthews, New York Giants wide receiver Victor Cruz, New England Patriots wide receiver Danny Amendola and Tampa Bay Buccaneers running back Doug Martin — to talk about the importance of precision both on the gridiron and in the equipment needed to tackle shaving, even on sensitive skin.
“In shaving and in sport, precision makes the difference,” stated Greg Via, Gillette’s director of global sports marketing. “On the field, these players embody precision at its highest level, and we are excited to work with such a talented group. At Gillette, we have spent the last 110 years refining and carefully engineering our razors to give every man the advantage of Gillette’s precision.”
To give fans the chance to test their own precision when it comes to football, Gillette is launching a “Precision Play of the Week” trivia game on Facebook, featuring John Brenkus, creator/ host of Sport Science. Each week, Brenkus will provide a scientific breakdown of one of the prior week’s best plays. Fans will be invited to answer a question related to the play for the chance to win various prizes, with the grand prize being a trip to Super Bowl XLVIII in New York.
Upsher-Smith launches morphine sulfate capsules
MAPLE GROVE, Minn. — A new opioid painkiller drug made by Upsher-Smith Labs will become available on Wednesday, the drug maker said.
Upsher-Smith said it would launch its morphine sulfate extended-release capsules in the 10-mg, 20-mg, 30-mg, 50-mg, 60-mg, 80-mg and 100-mg strengths.
The company said its product would be the first generic entrant for the 10-mg extended-release capsule dosage strength, adding that there have historically been a limited number of morphine sulfate generics available.